Selected Highlights of the 9th Molecular Cytopathology Meeting

Dear Colleagues,

Molecular cytopathology is a rapidly evolving field, based on the interplay between traditional microscopy and molecular pathology. Any molecular assay that has been developed on formalin-fixed, paraffin-embedded material can also be performed on any cytology sample with appropriate validation. However, the complexity of the preanalytical aspects, reflected in the wide range of preparations, fixation, and staining techniques adopted in different cytology laboratories, the need for a rigorous validation protocol, and the specific clinical applications require a conscious and ongoing effort to fully exploit the vast potential offered by minimally invasive cytology samples. Thus, in order to engage in a timely update on the increasing number and variety of molecular tests performed on cytologic specimens, the University of Naples Federico II has been organizing an annual molecular cytopathology meeting since 2010, providing a perspective on the evolution of molecular pathology in the field of cytopathology with updates on cytological and molecular classifications.

Even in these dramatic times of the COVID-19 pandemic, to keep the pathologists and the medical community in general updated on those aspects of modern cytopathology and molecular cytopathology, the 9th edition of the “Molecular Cytopathology Meeting”, directed by Giancarlo Troncone (University of Naples Federico II, Naples, Italy), together with Sinchita Roy-Chowdhuri (The University of Texas MD Anderson Cancer Center, Houston, Texas, USA) and Maria Dolores Lozano (University Clinic of Navarra, Pamplona, Spain), has been organized as a virtual meeting. An international perspective of the practice of molecular cytopathology aims at both engaging pathologists with the clinical and therapeutic aspects of oncology and at engaging clinicians with the challenges of molecular testing on small tissue samples and standardization of molecular cytopathology methods. This Special Issue will reflect the content of the congress sessions on thyroid, pancreatobiliary, salivary gland, lung, cervical cytology, urine, serous fluid and breast, and COVID-19.

Prof. Dr. Giancarlo Troncone
Prof. Philippe Vielh
Dr. Pasquale Pisapia
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Molecular Pathology is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.